News & Insights

U.S. HHS Recommends Cannabis Move to Schedule III of the Controlled Substances Act
Cannabis David Pejovic Cannabis David Pejovic

U.S. HHS Recommends Cannabis Move to Schedule III of the Controlled Substances Act

On August 30, 2023, the U.S. Department of Health and Human Services (HHS) recommended to the U.S. Drug Enforcement Administration (DEA) that cannabis, currently a schedule I controlled substance, be reclassified as a schedule III controlled substance under U.S. federal law. This recommendation, if adopted by the DEA, could have a monumental impact on the U.S. state legal cannabis industry. 

Read More
Chicago Atlantic Commits $150 million to New York Social Equity Cannabis Investment Fund
Business, Cannabis David Pejovic Business, Cannabis David Pejovic

Chicago Atlantic Commits $150 million to New York Social Equity Cannabis Investment Fund

New York Governor Kathy Hochul announced on June 30 that Chicago Atlantic Admin LLC has committed an investment of $150 million in the state’s Social Equity Cannabis Investment Fund. The funds will be disbursed as low-interest loans and provide hope for needed financing for justice-impacted individuals leading companies that have received Conditional Adult Use Retail Dispensary (CAURD) licenses.

Read More
5 Tips to a Successful “Distressed” Cannabis/Psychedelics Acquisition
Business David Pejovic Business David Pejovic

5 Tips to a Successful “Distressed” Cannabis/Psychedelics Acquisition

Whether players in the cannabis and psychedelics industries like it or not, the era of acquisitions of troubled or struggling companies is here. Access to capital, the mother’s milk of these industries, has been severely restricted for over a year. As losses continue, debt matures and defaults grow, businesses seek strategic alternatives including M&A.

Read More